Related Experiment Video
Updated: Jun 23, 2026

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Abstract:
(1) Although patients experience the adverse effects of drugs, they are rarely allowed to report adverse effects directly to their national pharmacovigilance system; (2) An analysis of direct patient reporting to pharmacovigilance centres, and surveys of patient reporting, show that patients mention some adverse effects previously overlooked by healthcare professionals; (3) Patients' reports of adverse effects can have strong causal links and contain as much information as healthcare professionals' reports; (4) Patients do not use the same vocabulary as healthcare professionals, making it more time-consuming for pharmacists and physicians to classify their reports using existing analytical tools; (5) In practice, patients will ultimately benefit from the increased knowledge concerning adverse effects if healthcare authorities allow them to participate directly in pharmacovigilance.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios
Types of Reports III: Telephone and Verbal Reports
Here's an overview of each type:
Telephone Orders
Therapeutic Drug Monitoring: Affecting Factors
Drug Regulation
Drug Product Performance: In Vitro–In Vivo Correlation